We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Review · September 08, 2020

T-VEC May Be Used Concurrently With or After Anti–PD-1–Based Therapy

Melanoma Management

 

Additional Info

Melanoma Management
Observational Study of Talimogene Laherparepvec Use in the Anti-PD-1 Era for Melanoma in the United States (COSMUS-2)
Melanoma Manag 2020 Jun 15;7(2)MMT41, J Sun, BR Gastman, L McCahon, et al

Further Reading